Olivier Litzka
Member of the Advisory Board
Board of Directors
RADUGA-3-Co-operative
Germany
Biography
Olivier Litzka is a partner at Edmond de Rothschild Investment Partners (EdRIP) since 2006. Olivier is also a member of the boards of Autonomic Technologies Inc., Noxxon Pharma, JenaValve and SuperSonic Imagine. Up to their acquisition, he was also a member of the boards of Novexel, Endosense, Sapiens Steering Brain Stimulation Stimulation, and the public company Probiodrug.
Research Interest
Before EdRIP, Olivier spent six years with 3i’s life science venture capital practice, before which he worked as a strategy consultant with Mercer Management Consulting. Olivier holds a PhD in molecular microbiology from the Institut für Mikrobiologie at the University of Munich
